Catheter Introducer Sheaths Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Catheter Introducer Sheaths Market size was valued at USD 1.4 billion in 2026 and is anticipated to grow at a 7.13% CAGR from 2027 to 2036, exceeding USD 2.79 billion by 2036. The industry revenue for 2027 is calculated at USD 1.48 billion.
Get more details on this report
Request Free Sample ReportCatheter Introducer Sheaths Market Intelligence Snapshot
Regional Market Dynamics
- North America accounts for 42.72% share, supported by high cardiovascular and interventional procedure volumes, mature hospital infrastructure, and consistent use of minimally invasive catheter-based access systems.
- Asia Pacific is growing at 8.59% CAGR, driven by expanding interventional care capacity, hospital infrastructure upgrades, and increasing adoption of vascular and cardiac minimally invasive procedures.
Segment Momentum
- Hospitals held the largest share at 62.48% in 2026, supported by high volumes of vascular and interventional procedures, broad clinical use, and the infrastructure needed for consistent sheath utilization.
- Separable introducer sheaths are gaining traction because they allow efficient removal without disrupting placed catheters or leads, supporting greater procedural flexibility and smoother device management.
Market Expansion Drivers
- Rising cardiovascular disease burden increasing demand for interventional catheter access devices.
- Increasing cardiac and vascular procedures driving utilization of advanced introducer sheath systems.
- Expansion of minimally invasive cardiac interventions accelerating sheath innovation and uptake.
Leading Market Participants
- Leading players in the catheter introducer sheaths market include Terumo Corporation (Japan), Medtronic plc (Ireland), Merit Medical Systems, Inc. (United States), Abbott Laboratories (United States), Becton, Dickinson and Company (United States), Cordis Corporation (United States), B. Braun Melsungen AG (Germany), Stryker Corporation (United States), Oscor Inc. (United States), Galt Medical Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.4 billion
- 2027 Estimated Market Size: USD 1.48 billion.
- Projected Market Size: USD 2.79 billion by 2036
- Growth Forecast: 7.13% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Integrated Introducer Sheaths (Product) | Hospitals (End-use)
- Emerging Opportunity Segment: Separable Introducer Sheaths (Product) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising cardiovascular disease burden increasing demand for interventional catheter access devices
The increasing burden of cardiovascular disease will drive the catheter introducer sheaths market by expanding the need for minimally invasive diagnostic and therapeutic procedures requiring dependable vascular access. Conditions affecting the heart and blood vessels often require catheter-based interventions that depend on secure access points for the introduction and exchange of medical devices. Introducer sheaths provide a controlled pathway for catheters and other instruments while supporting procedural efficiency, making them an important component of interventional cardiovascular care.
Increasing cardiac and vascular procedures driving utilization of advanced introducer sheath systems
Growing numbers of cardiac and vascular interventions are strengthening the catheter introducer sheaths market as clinicians increasingly depend on access devices suited to complex procedural requirements. Modern sheath systems can incorporate features such as improved flexibility, hemostasis control, kink resistance, and compatibility with different catheter sizes, allowing physicians to navigate challenging vascular pathways more effectively. Expansion of procedures involving catheter-based diagnosis, treatment, and device delivery is therefore increasing the need for specialized introducer systems across interventional settings.
Expansion of minimally invasive cardiac interventions accelerating sheath innovation and uptake
The shift toward minimally invasive cardiac treatment will propel the catheter introducer sheaths market by creating demand for access technologies capable of supporting increasingly sophisticated catheter-based procedures. Compared with open surgical approaches, minimally invasive interventions require carefully engineered access components that facilitate device delivery while limiting vascular trauma and procedural disruption. Manufacturers are consequently developing sheath designs with improved maneuverability, profile characteristics, hemostatic performance, and compatibility with advanced interventional devices, supporting their use across evolving cardiac treatment techniques.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular disease burden increasing demand for interventional catheter access devices | 2.00% | High | North America, Europe | High | Near Term |
| Increasing cardiac and vascular procedures driving utilization of advanced introducer sheath systems | 1.80% | High | Global | High | Near Term |
| Expansion of minimally invasive cardiac interventions accelerating sheath innovation and uptake | 1.50% | Moderate | Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the catheter introducer sheaths market, North America held the largest share in 2026 at 42.72%, supported by advanced interventional healthcare infrastructure and widespread adoption of minimally invasive cardiovascular and endovascular procedures. The region's mature procedural ecosystem encourages the use of reliable access devices that facilitate catheter placement while supporting procedural efficiency and patient safety. Continued investment in specialized healthcare facilities, experienced clinical workforces, and sophisticated interventional techniques further reinforces demand for introducer sheaths.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region, benefiting from expanding access to interventional medicine, rising healthcare expenditure, and the modernization of hospitals and catheterization facilities. Increasing adoption of minimally invasive treatment approaches and improving clinical capabilities are expected to broaden the use of catheter introducer sheaths across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Cardiology Lab StandardizationGermany’s catheter introducer sheath utilization is strongly driven by standardized cardiac catheterization laboratory protocols, with emphasis on procedural precision and safety. In Germany, hospitals favor high-quality sheath systems that support consistent vascular access outcomes across diagnostic angiography and interventional cardiology procedures under strict clinical guidelines.
France 🇫🇷
Hospital Device Procurement ControlFrance’s catheter introducer sheath adoption is shaped by centralized hospital procurement systems and tender-based purchasing, particularly within public healthcare facilities. In France, clinicians and administrators prioritize standardized sheath products that meet regulatory requirements while ensuring consistent performance in interventional cardiology and vascular access procedures.
Italy 🇮🇹
Vascular Access Procedure GrowthItaly’s use of catheter introducer sheaths is increasing across cardiology and vascular access procedures within hospital systems, driven by broader adoption of minimally invasive interventions. In Italy, clinicians focus on reliable sheath performance to support diagnostic angiography and interventional treatments across regional and urban healthcare facilities.
Japan 🇯🇵
Minimally Invasive Access TrendsJapan’s adoption of catheter introducer sheaths is influenced by a strong preference for minimally invasive cardiovascular and endovascular procedures, particularly among an aging patient population. In Japan, hospitals emphasize small-caliber, high-precision sheath systems that reduce vascular complications and support safer interventional access in complex cases.
South Korea 🇰🇷
Cath Lab Expansion AdoptionSouth Korea’s expanding catheterization laboratory infrastructure is driving adoption of advanced introducer sheath systems in tertiary care hospitals. In South Korea, clinicians prioritize devices that enhance procedural speed and safety during interventional cardiology and radiology procedures, supporting growing demand for minimally invasive cardiovascular treatments.
United States 🇺🇸
Interventional Access PreferenceCatheter introducer sheaths in the United States are widely used in interventional cardiology and radiology settings, where procedural efficiency and vascular access safety are critical. In the U.S., hospitals prioritize sheath systems that reduce insertion time and improve hemostasis management during complex catheter-based diagnostic and therapeutic procedures.
Segment Leadership and Growth Trends
Catheter Introducer Sheaths Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Integrated Introducer Sheaths (Largest Segment) vs Separable Introducer Sheaths (Fastest-Growing Segment)
Integrated introducer sheaths accounted for the largest share of 58.39% in 2026 in the catheter introducer sheaths market, supported by their streamlined configuration and ability to facilitate efficient vascular access during minimally invasive procedures. Their integrated design can simplify device handling and provide a stable pathway for catheter and other interventional equipment. Increasing utilization of catheter-based cardiovascular and vascular procedures, together with clinician preference for reliable access systems that support procedural efficiency, continues to sustain demand for integrated sheath solutions.
Separable introducer sheaths are expected to be the fastest-growing product segment, driven by their flexibility in procedures where controlled removal of the sheath around an indwelling catheter or other device is advantageous. Their design can support complex interventions by allowing clinicians to adapt the access system according to procedural requirements. Increasing adoption of minimally invasive techniques and the growing need for specialized access solutions in advanced interventions are creating additional opportunities for separable sheath technologies.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
The hospitals segment led the catheter introducer sheaths market with a 62.48% share in 2026, reflecting the high volume of complex interventional procedures performed in hospital environments. Hospitals provide access to specialized clinicians, advanced imaging and catheterization infrastructure, and comprehensive emergency and postoperative support, making them a primary setting for procedures requiring introducer sheaths. The continued use of minimally invasive cardiovascular and vascular interventions is therefore reinforcing demand through hospital-based procedural departments.
Ambulatory surgical centers are expected to be the fastest-growing end-use segment as healthcare delivery increasingly shifts selected minimally invasive procedures toward outpatient settings. These facilities offer shorter stays, streamlined workflows, and potentially lower treatment burdens for appropriate procedures, encouraging the migration of certain interventions away from traditional inpatient environments. Expanding procedural capabilities and growing demand for efficient outpatient care are supporting greater use of catheter introducer sheaths in ambulatory settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Integrated Introducer Sheaths, Separable Introducer Sheaths | Integrated Introducer Sheaths | Separable Introducer Sheaths |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Key companies in the catheter introducer sheaths market:
1. Terumo Corporation (Japan)
2. Medtronic plc (Ireland)
3. Merit Medical Systems Inc. (United States)
4. Abbott Laboratories (United States)
5. Becton Dickinson and Company (United States)
6. Cordis Corporation (United States)
7. B. Braun Melsungen AG (Germany)
8. Stryker Corporation (United States)
9. Oscor Inc. (United States)
10. Galt Medical Corporation (United States)
Rising procedural volumes and demand for minimally invasive interventions are influencing strategic developments within the catheter introducer sheaths market. Market participants are focusing on sheath flexibility, precision control, and improved insertion technologies to enhance procedural efficiency and patient safety. Product advancements targeting reduced complications and smoother vascular access procedures are also contributing to competitive differentiation in the catheter introducer sheaths market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Terumo Corporation (Japan) | |||||||
| Medtronic plc (Ireland) | |||||||
| Merit Medical Systems Inc. (United States) | |||||||
| Abbott Laboratories (United States) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Cordis Corporation (United States) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Stryker Corporation (United States) | |||||||
| Oscor Inc. (United States) | |||||||
| Galt Medical Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Argon Medical Devices | Sep-24 | Argon Medical Devices launched the Intara Introducer Sheath, engineered for peripheral and central vascular access. Designed to improve procedural efficiency and device delivery, this launch expands the company’s interventional radiology portfolio and strengthens its commercial position in the market for vascular access solutions. |
| EOSolutions Corp. | Oct-23 | EOSolutions Corporation received U.S. FDA clearance for its Thinline introducer sheath. Designed to complement the company's Dr. Banner balloon guide catheter, this 8Fr-compatible sheath reduces closure size requirements, facilitating enhanced procedural flexibility and expanding the company's competitive offerings in the neurovascular interventional market. |
| Merit Medical | Jun-23 | Merit Medical acquired a portfolio of dialysis catheters and the BioSentry biopsy tract sealant system from AngioDynamics for USD 100 million, alongside the Surfacer Inside-Out access system from Bluegrass Vascular Technologies for USD 32.5 million. These acquisitions broaden Merit's therapeutic platform and increase its presence in vascular access and interventional biopsy markets. |
| Abbott | Feb-23 | Abbott entered a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI) for approximately USD 890 million. This acquisition integrates CSI's innovative orbital atherectomy system into Abbott's vascular device portfolio, enhancing its capability to treat complex peripheral and coronary artery disease and reinforcing its position in the vascular intervention market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Catheter Introducer Sheaths Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Access Site | Femoral Access, Radial Access, Brachial Access, Other Peripheral Access |
| Procedure Type | Cardiac Catheterization, Peripheral Vascular Intervention, Electrophysiology Procedures, Structural Heart Procedures |
| Physician Specialty | Interventional Cardiology, Vascular Surgery, Interventional Radiology, Electrophysiology |
Catheter Introducer Sheaths Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Catheterization Laboratory Procurement Assessment |
|
| Vascular Access Practice Trends and Adoption Analysis |
|
| Emerging Growth Opportunities in Minimally Invasive Interventions |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the catheter introducer sheaths market?
How is the catheter introducer sheaths industry size expected to evolve during the forecast period?
How is the growth of minimally invasive cardiac interventions reshaping product demand in the catheter introducer sheaths market?
Which purchasing priorities are driving adoption of advanced introducer sheath systems?
Which end-use segment dominates the catheter introducer sheaths market?
Why are separable introducer sheaths the fastest-growing product segment?
Why does North America dominate catheter introducer sheaths market?
What factors are driving Asia Pacific growth in catheter introducer sheaths market?
Who are the leading players in the catheter introducer sheaths landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization